Elevated Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Elevated Financial Group's LLY Position: Q3 2026 in Review
Elevated Financial Group reduced its Eli Lilly (LLY) stake by 21% in Q3 2026, selling an estimated $248K and leaving 776 shares worth $898K. The position accounts for 0.25% of the portfolio, ranked #49.
Elevated Financial Group first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.22M in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Elevated Financial Group held 776 shares of Eli Lilly worth $898K as of Q3 2026.
- Elevated Financial Group sold 210 Eli Lilly shares in Q3 2026, an estimated $248K.
- Eli Lilly made up 0.25% of Elevated Financial Group's portfolio in Q3 2026, its #49 holding.
- Elevated Financial Group first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- Elevated Financial Group's Eli Lilly position peaked at $3.22M in Q1 2026.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Elevated Financial Group's 13F filing for Q3 2026, filed 16 Oct 2026.